Effects of postmortem heparinization in canine lung transplantation with non-heart-beating donors

J Thorac Cardiovasc Surg. 2005 Feb;129(2):429-34. doi: 10.1016/j.jtcvs.2004.05.009.

Abstract

Objective: Microthrombus formation appears to be one of the major detrimental factors in lung transplantation from non-heart-beating donors. The purpose of this study was to evaluate the effects of postmortem heparinization by closed-chest cardiac massage in a canine model of left single-lung allotransplantation from non-heart-beating donors.

Methods: Left lung transplantation was performed in 18 weight-matched pairs of mongrel dogs. Donors were killed with an intravenous injection of potassium chloride and left at room temperature for 2 hours. The cadaveric donors were assigned randomly to one of the three groups. In group 1 (n = 6), no heparin was given as a control. In group 2 (n = 6), heparin sodium (1000 U/kg) was administered intravenously before cardiac arrest. In group 3 (n = 6), heparin sodium (1000 U/kg) was administered intravenously 10 minutes after death, then closed-chest cardiac massage was performed for 2 minutes. After 2 hours of cardiac arrest, donor lungs were flushed with low-potassium dextran-glucose solution and preserved for 60 minutes. After left lung transplantation, the right pulmonary artery was ligated, and recipient animals were followed up for 3 hours. Univariate and multivariate repeated analyses were used for statistics.

Results: Both groups 2 and 3 had significantly better gas exchange and lower pulmonary vascular resistance than group 1. Changes in thrombin-antithrombin III complex concentration during the warm ischemia indicated that postmortem heparinization suppressed clotting activation in the donor.

Conclusions: Postmortem heparinization by cardiac massage is beneficial in lung transplantation from non-heart beating donors by preventing microthrombus formation.

Publication types

  • Comparative Study
  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anticoagulants / pharmacology*
  • Antithrombin III / drug effects
  • Antithrombin III / metabolism
  • Biomarkers / blood
  • Disease Models, Animal
  • Dogs
  • Heart / drug effects*
  • Heart / physiopathology
  • Heart Arrest, Induced*
  • Heart Massage
  • Heparin / pharmacology*
  • Lung / drug effects*
  • Lung / metabolism
  • Lung / pathology*
  • Lung Transplantation*
  • Models, Cardiovascular
  • Peptide Hydrolases / drug effects
  • Peptide Hydrolases / metabolism
  • Postmortem Changes*
  • Respiratory Function Tests
  • Vascular Resistance / drug effects
  • Vascular Resistance / physiology
  • Whole Blood Coagulation Time

Substances

  • Anticoagulants
  • Biomarkers
  • antithrombin III-protease complex
  • Antithrombin III
  • Heparin
  • Peptide Hydrolases